Squarepoint
COGT icon

Squarepoint’s Cogent Biosciences COGT Stock Holding History

Squarepoint’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.71M Buy
226,259
+70,275
+45% +$2.59M 0.01% 1147
2025
Q4 		$5.54M Buy
+155,984
New +$4.38M 0.01% 1393
2025
Q3 		– Sell
-101,518
Closed -$729K – 4437
2025
Q2 		$729K Buy
+101,518
New +$563K ﹤0.01% 2934
2025
Q1 		– Sell
-128,799
Closed -$1M – 4696
2024
Q4 		$1M Buy
128,799
+117,939
+1,086% +$1.18M ﹤0.01% 3061
2024
Q3 		$117K Buy
+10,860
New +$106K ﹤0.01% 3839
2024
Q2 		– Sell
-16,843
Closed -$113K – 4135
2024
Q1 		$113K Buy
16,843
+566
+3% +$3.5K ﹤0.01% 3775
2023
Q4 		$95.7K Buy
+16,277
New +$125K ﹤0.01% 3760
2023
Q2 		– Sell
-25,958
Closed -$280K – 3621
2023
Q1 		$280K Sell
25,958
-37,192
-59% -$476K ﹤0.01% 2615
2022
Q4 		$730K Buy
+63,150
New +$783K ﹤0.01% 2048
2022
Q1 		– Sell
-10,475
Closed -$90K – 2916
2021
Q4 		$90K Buy
+10,475
New +$91.1K ﹤0.01% 2942
2021
Q2 		– Sell
-10,290
Closed -$90K – 3286
2021
Q1 		$90K Sell
10,290
-1,982
-16% -$19.1K ﹤0.01% 2920
2020
Q4 		$138K Sell
12,272
-12,067
-50% -$133K ﹤0.01% 2635
2020
Q3 		$228K Buy
+24,339
New +$254K ﹤0.01% 2002
2018
Q4 		– Sell
-4,850
Closed -$200K – 1978
2018
Q3 		$200K Buy
+4,850
New +$273K ﹤0.01% 1775

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Squarepoint's COGT Position: Q1 2026 in Review

Squarepoint increased its Cogent Biosciences (COGT) stake by 45% in Q1 2026, buying an estimated $2.59M and bringing the position to 226,259 shares worth $8.71M. The position accounts for 0.01% of the portfolio, ranked #1147.

Squarepoint first reported a position in COGT in Q3 2018 and has held it in 14 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Squarepoint held 226,259 shares of Cogent Biosciences worth $8.71M as of Q1 2026.
  • Squarepoint bought 70,275 Cogent Biosciences shares in Q1 2026, an estimated $2.59M.
  • Cogent Biosciences made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1147 holding.
  • Squarepoint first reported a position in Cogent Biosciences in Q3 2018 and has held it in 14 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.